Industry News
Sickle cell pain improved by arginine therapy
Sep 19, 2013
Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain... Read More
Unusual combination therapy shows promise for preventing prostate cancer, UPCI researchers find
Sep 18, 2013
Combining a compound from broccoli with an antimalarial drug prevents prostate cancer in mice, University of Pittsburgh Cancer Institute (UPCI) researchers discovered. The National Cancer Institute-funded research will be published in the Oct. 1 issue of the journal Cancer Research... Read More
Researchers identify new target for melanoma treatment
Sep 18, 2013
Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have announced the discovery that a gene encoding an enzyme, phosphoinositide-dependent kinase-1 (PDK1), plays an essential role in the development and progression of melanoma. The finding offers a new approach to treating this life-threatening disease. The team of researchers, led by Ze'ev Ronai, Ph.D... Read More
Unusual combination therapy shows promise for preventing prostate cancer, UPCI researchers find
Sep 18, 2013
Combining a compound from broccoli with an antimalarial drug prevents prostate cancer in mice, University of Pittsburgh Cancer Institute (UPCI) researchers discovered. The National Cancer Institute-funded research will be published in the Oct. 1 issue of the journal Cancer Research... Read More
Researchers identify mechanisms that oversee the development of a pro-tumor network
Sep 18, 2013
Researchers at Roswell Park Cancer Institute (RPCI) have uncovered a new pathway by which cancer cells, such as in breast cancer, stimulate the expansion of myeloid-derived suppressor cells (MDSCs), a blood cell population known to interfere with the body's anti-tumor response... Read More
Vanderbilt study targets DNA of cancer cell drug resistance
Sep 18, 2013
Targeted cancer therapies - drugs that kill cancer cells with certain "driver oncogenes" - shrink tumors and extend patient survival. Ultimately though, the cancers become resistant to the targeted therapies. "Unfortunately, virtually all patients with metastatic cancer develop disease progression, limiting the effectiveness of these agents," said William Pao, M.D., Ph.D... Read More
UC Davis study applies timely cost-effectiveness analysis to state breast cancer screening program
Sep 18, 2013
When public health budgets are constrained, mammography screening should begin later and occur less frequently, a cost-effectiveness analysis for California's Every Woman Counts (EWC) program concludes... Read More
Gene therapy study produces promising results for patients with hemophilia B
Sep 18, 2013
A fraction of patients with a common form of the bleeding disorder hemophilia develop an allergic reaction to the blood-clotting treatment they need to keep them alive... Read More
Researchers identify new target for melanoma treatment
Sep 18, 2013
Scientists at Sanford-Burnham Medical Research Institute (Sanford-Burnham) have announced the discovery that a gene encoding an enzyme, phosphoinositide-dependent kinase-1 (PDK1), plays an essential role in the development and progression of melanoma. The finding offers a new approach to treating this life-threatening disease. The team of researchers, led by Ze'ev Ronai, Ph.D... Read More
Cancer cell growth encouraged by specific sugar molecule
Sep 18, 2013
The process of glycosylation, where sugar molecules are attached to proteins, has long been of interest to scientists, particularly because certain sugar molecules are present in very high numbers in cancer cells. It now turns out that these sugar molecules are not only present but actually aid the growth of the malignant cells... Read More
Previous Page Next Page